Extreme Fighting Championship (EFC) and M2Bio Sciences have announced a new partnership that the two parties say will “revolutionise sports science and athlete health”.
M2Bio Sciences is a biomedical research company dedicated to alternative and integrative treatments for various health conditions.
Their core research interests lie in the medicinal capacity of cannabinoids (the active compounds in cannabis) and psilocybin (the active compound found in certain mushrooms).
HAVE YOU ALSO LISTENED TO?: Podcast – ‘At Home with Dylan Rogers’ – Dricus du Plessis
Currently, most of their research is done at the University of Pretoria and they have three consumer brands – Medspresso, Dr Annarx, and Liviana – which consist of a range of cannabidiol-infused products.
M2Bio Sciences and EFC will collaborate in the field of neurotrauma, with M2Bio Sciences integrating their research program with the brain health of EFC competitors, whilst presenting a health and wellness product range being developed with EFC Lightweight contender Rob Simbowe.
M2Bio Sciences will also contribute to the financial investment in EFC athletes, enhancing athlete pay, whilst ensuring the line-up continues to benefit from the best medical support available.